交付策略,以实现治疗性心肌血管新生
R Kornowski1, S Fuchs, M B Leon
1Cardiovascular Research Foundation, Washington Hospital Center, Washington DC 20010, USA. rxk3@mhg.edu
Circulation
|February 2, 2000
概括
探索新的心血管疾病治疗方法,这项研究审查了提供血管性因素以改善心血管功能的方法. 它比较了治疗性心肌血管生成的输送策略,这对于治疗缺血性心脏病至关重要.
科学领域:
- 心血管医学 心血管医学
- 再生医学是一种再生医学.
- 分子生物学分子生物学
背景情况:
- 治疗性血管生成旨在改善缺血性心肌中的血液供应.
- 在临床前模型中,重组基因和生长因子显示出前景.
- 心肌血管新生治疗的最佳输送策略尚不清楚.
研究的目的:
- 审查和比较治疗性心肌血管生成的不同给药途径.
- 为了确定最安全和最有效的输送策略,在缺血性心脏病的血管性因素.
主要方法:
- 对血管新生因子通过导管,手术内和心脏内输送的现有文献的审查.
- 分析实验模型和正在进行的临床试验,用于心肌血管生成疗法.
主要成果:
- 冠内输送在精确的定位和全身暴露方面存在局限性.
- 内心肌内注射在实验和临床环境中表现有前途.
- 腹腔内输送可能会提供长时间的组织暴露.
结论:
- 治疗性心肌血管生成的最佳输送方法需要进一步研究.
- 对比各种血管新生因子输送策略的风险和益处对于临床应用至关重要.
相关概念视频
Aortic Regurgitation IV: Nursing Management
453
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
453
Coronary Artery Disease V: Interprofessional Care
444
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome IV: Interprofessional Care
522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
Heart Failure V: Medical Management
626
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626
Heart Failure VI: Adjunct Therapies
632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753


